To Determine Tolerability to Glucagon Infusion in Obese Subjects

NCT02817659 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Obesity

Interventions

DRUG: Glucagon

Sponsor

AdventHealth Translational Research Institute